Tuberculosis pleural effusion full details for md exam answer 15 marks structured answer
Reading File
Now let me read the PDF skill and search all sources in parallel:
Reading File
Finding Sources
Finding Sources
Now let me read the key textbook sections and the attached PDFs in parallel:
Reading File
Reading File
Running Command
python3 -c " import pdfplumber # Read Sharma Mohan PDF - search for TB pleural effusion path = '/home/daytona/workspace/attachments/01d1338f-01ed-46b7-baf5-7fa344d16def/Sharma mohan latest_compressed-compressed (1).pdf' with pdfplumber.open(path) as pdf: print(f'Total pages: {len(pdf.pages)}') # Search for TB pleural effusion content for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('tubercul' in text.lower() or 'pleural effusion' in text.lower()): print(f'--- Page {i+1} ---') print(text[:2000]) print() " 2>&1 | head -300
Running Command
python3 -c " import pdfplumber # Read Light's pleural disease PDF path = '/home/daytona/workspace/attachments/01d1338f-01ed-46b7-baf5-7fa344d16def/lights pleural dz_compressed.pdf' with pdfplumber.open(path) as pdf: print(f'Total pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages): text = page.extract_text() if text and 'tubercul' in text.lower(): print(f'--- Page {i+1} ---') print(text[:2500]) print() " 2>&1 | head -400
The PDFs appear compressed. Let me read the Murray & Nadel TB pleural section directly and extract more from the PDFs:
Reading File
Running Command
python3 -c " import pdfplumber # Try Sharma Mohan PDF with different approach path = '/home/daytona/workspace/attachments/01d1338f-01ed-46b7-baf5-7fa344d16def/Sharma mohan latest_compressed-compressed (1).pdf' with pdfplumber.open(path) as pdf: print(f'Total pages: {len(pdf.pages)}') # Get first few pages to see content structure for i in range(min(5, len(pdf.pages))): text = page = pdf.pages[i].extract_text() if text: print(f'--- Page {i+1} ---') print(text[:500]) print() " 2>&1
Finding Sources
Excellent! The Sharma Mohan PDF is the TB textbook. Let me extract the TB pleural effusion chapter from it, and continue reading Murray & Nadel's detailed section:
Running Command
python3 -c " import pdfplumber path = '/home/daytona/workspace/attachments/01d1338f-01ed-46b7-baf5-7fa344d16def/Sharma mohan latest_compressed-compressed (1).pdf' with pdfplumber.open(path) as pdf: # Find TB pleural effusion chapter for i, page in enumerate(pdf.pages): text = page.extract_text() if text and ('pleural' in text.lower()) and ('tubercul' in text.lower()): # Check for chapter headings if any(kw in text.lower() for kw in ['chapter', 'pleuritis', 'pleural tuberculosis', 'pleural effusion']): print(f'--- Page {i+1} ---') print(text[:3000]) print() " 2>&1 | head -500
Reading File
Let me now read the TB pleural treatment/diagnosis section from Murray & Nadel and extract content from Sharma Mohan PDF more specifically:
Reading File
Running Command
python3 -c " import pdfplumber path = '/home/daytona/workspace/attachments/01d1338f-01ed-46b7-baf5-7fa344d16def/Sharma mohan latest_compressed-compressed (1).pdf' with pdfplumber.open(path) as pdf: # Search more broadly for pleural content found_pages = [] for i, page in enumerate(pdf.pages): text = page.extract_text() if text and 'pleural' in text.lower(): found_pages.append(i+1) print('Pages with pleural content:', found_pages[:30]) # Print first matching page in full if found_pages: pg = pdf.pages[found_pages[0]-1].extract_text() print(f'--- Page {found_pages[0]} content ---') print(pg[:3000]) " 2>&1
I now have excellent detailed content from Murray & Nadel. Let me read the diagnostic section more fully:
Reading File
Reading File
I now have comprehensive content. Let me also fetch the TB effusion X-ray/CT image from the textbook:
Loading Image
I now have all the information needed. Let me compile the comprehensive 15-mark structured MD exam answer.---
TUBERCULOSIS PLEURAL EFFUSION
MD Examination Answer — 15 Marks
1. INTRODUCTION & EPIDEMIOLOGY (1 mark)
Tuberculous (TB) pleural effusion is the most common cause of an exudative pleural effusion in many parts of the world, particularly in developing nations where TB is endemic. In some African countries, pleural TB represents >30% of all TB cases, a high incidence partly attributable to HIV co-infection. It is relatively uncommon in the United States (~3.6% of all TB cases). The condition may represent either primary TB (occurring 3–6 months after initial infection) or reactivation TB.
2. PATHOGENESIS (2 marks)
Tuberculous pleural effusion results from the rupture of a subpleural caseous focus into the pleural space, introducing mycobacterial antigens. Two overlapping mechanisms operate:
A. Delayed Hypersensitivity (Classical theory)
- Sensitised T-lymphocytes react to mycobacterial proteins in the pleural space
- Rapid exudative effusion results from increased vascular permeability driven by cytokines
- Animal studies: intrapleural tuberculin injection in sensitized guinea pigs → immediate exudate; blocked by antilymphocyte serum
- Supported by the historically negative culture rates (~80%) in pleural fluid
B. Paucibacillary Direct Infection (Modern understanding)
- Improved culture techniques (liquid media + biopsy) now identify bacilli in >60% of cases
- Tuberculous pleuritis = paucibacillary infection with subsequent intense immunologic reaction
- Initial response: neutrophil-predominant acute inflammation → evolves into lymphocyte-driven chronic reaction with granuloma formation
- Lymphocyte activity inversely correlates with culture positivity — sufficient lymphocytes can sterilize the pleural space (explains spontaneous resolution)
TB Pleuritis vs. TB Empyema — a spectrum:
| Feature | TB Pleuritis | TB Empyema |
|---|---|---|
| Mechanism | Paucibacillary + immune reaction | High mycobacterial load |
| Fluid | Serous/lymphocytic exudate | Purulent |
| Culture | Usually negative | Positive |
| Spontaneous resolution | Possible | Unlikely |
HIV co-infection alters pathogenesis: effusions more common when CD4 >200 cells/μL (delayed hypersensitivity still operative); systemic features more prominent; culture-positive effusions more frequent.
3. CLINICAL FEATURES (2 marks)
Presentation pattern:
- Acute illness (~two-thirds of cases): mimics bacterial pneumonia — cough, pleuritic chest pain (~75%), fever, dyspnea
- Chronic illness (~one-third): low-grade fever, weakness, anorexia, weight loss, night sweats
Characteristics of the effusion:
- Almost always unilateral
- Usually small to moderate in size; occasionally large enough to occupy the entire hemithorax
- Up to 86% have coexisting parenchymal disease on imaging; the effusion is almost always ipsilateral to the parenchymal lesion
- Even without radiographic parenchymal involvement, a subpleural focus is usually present (induced sputum positive in ~55% of such patients)
Rare complications:
- Dense parenchymal consolidation rupturing into pleural space → TB empyema (often with pneumothorax; high risk of bronchopleural fistula)
- Empyema necessitans: percutaneous decompression of TB empyema
- Fibrothorax: residual pleural fibrosis in ~50% of patients at 1 year
4. RADIOLOGICAL FEATURES (1 mark)
Tuberculous effusion and pneumonia. (A) PA CXR: left apical consolidation with left basal effusion. (B) CT chest: encapsulated posterior effusion with tree-in-bud changes anteriorly indicating parenchymal infection. (C) Mediastinal window: smooth lenticular pleural thickening — the "split-pleura" sign (arrows). — Murray & Nadel's Respiratory Medicine
- CXR: unilateral homogeneous opacity obliterating costophrenic angle; associated upper-lobe or apical consolidation; mediastinal shift if large
- CT chest: more sensitive; encapsulated/loculated collections; smooth pleural enhancement ("split-pleura" sign); mediastinal lymphadenopathy; tree-in-bud nodules indicating parenchymal involvement
- Ultrasound: confirms free vs. loculated effusion; guides thoracentesis
5. PLEURAL FLUID ANALYSIS (3 marks)
All TB pleural effusions are exudates (Light's criteria):
- Pleural fluid protein / serum protein > 0.5
- Pleural fluid LDH / serum LDH > 0.6
- Pleural fluid LDH > two-thirds upper normal serum LDH
Biochemistry:
| Parameter | Finding |
|---|---|
| Protein | >3 g/dL; often >5 g/dL (suggests TB pleuritis) |
| LDH | Elevated |
| Glucose | Usually normal; may be reduced |
| pH | Usually normal; may be reduced in empyema |
Cytology / Cell Count:
- Lymphocyte-predominant exudate (small lymphocytes) — the hallmark
- In ~11% of cases: PMN predominance (early disease)
- In ~17% of cases: lymphocytes <50%
- Mesothelial cells: characteristically absent or very sparse
Diagnostic Markers (most important for MD exam):
| Marker | Cut-off | Sensitivity | Specificity | Notes |
|---|---|---|---|---|
| Adenosine Deaminase (ADA) | >40 IU/L (Harrison's) / >50 U/L (Cecil) | ~90% | ~90% | Most useful; especially when effusion is lymphocytic; enzyme released by T-lymphocytes |
| Interferon-γ (IFN-γ) | >140 pg/mL | ~90% | ~97% | Direct ELISA measurement required; IFN-γ release assays on pleural fluid are insufficiently sensitive |
| PCR for mycobacterial DNA | Positive | Variable | High | Useful especially with negative cultures |
| Pleural fluid culture (AFB) | Positive | ~30–40% | 100% | Low yield; liquid media improves yield; time-consuming |
| Smear (AFB) | Positive | <10–20% | 100% | Very low sensitivity |
Key point: Combining ADA + differential cell count + clinical context substantially improves diagnostic accuracy. ADA >50 IU/L in a lymphocytic exudate is strongly suggestive.
6. DIAGNOSIS (2 marks)
The gold standard remains pleural biopsy demonstrating caseating granulomas or AFB.
Step-by-Step Diagnostic Approach:
Step 1 — Thoracentesis
- Send fluid for: biochemistry (protein, LDH, glucose), cytology + differential, AFB smear & culture, ADA, IFN-γ, PCR
Step 2 — Sputum examination
- Induced sputum for AFB smear and culture — positive in ~50% even without radiographic parenchymal disease
- MODS (Microscopic Observation Drug Susceptibility) assay: liquid culture with drug susceptibility; WHO-approved; faster, cheaper, provides resistance data
Step 3 — Pleural Biopsy (if thoracentesis inconclusive)
- Thoracoscopy (medical/VATS): ideal — highest yield, allows direct visualization and directed biopsy
- Image-guided percutaneous needle biopsy: has largely replaced closed biopsy in high-income settings
- Blind needle biopsy (Abrams needle): still important in high-TB-prevalence/resource-limited settings; combined with ADA + cell differential; ultrasound guidance improves yield
- Biopsy culture yield > pleural fluid culture yield
Diagnostic criteria:
- Caseating granuloma on pleural biopsy, OR
- AFB culture positive (fluid/biopsy/sputum), OR
- ADA >40 IU/L + lymphocytic exudate + compatible clinical picture + exclusion of other causes
7. TREATMENT (2 marks)
Antituberculous Therapy (ATT)
TB pleural effusion is treated with the same regimen as pulmonary TB:
| Phase | Duration | Drugs |
|---|---|---|
| Intensive phase | 2 months | Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E) → 2HRZE |
| Continuation phase | 4 months | Isoniazid + Rifampicin → 4HR |
| Total | 6 months |
Response to treatment:
- Fever resolves in ~2 weeks
- Effusion resolves within 6 weeks with treatment
- ~50% have mild residual pleural fibrosis at 1 year (usually no functional impairment)
Role of Corticosteroids
- May reduce time to resolution and degree of residual pleural fibrosis
- Evidence is of low quality; adverse events are more frequent
- Should only be initiated after commencing ATT
- Caution in HIV-infected patients (possible Kaposi sarcoma risk)
Fibrinolytic Agents (intrapleural)
- Proposed to improve drainage and reduce residual thickening
- Clinical significance of residual thickening is uncertain; routine use not established
Therapeutic Thoracentesis
- Large effusions causing significant dyspnea: drain to relieve symptoms
- Not routinely required for small-moderate effusions if patient is on ATT
Paradoxical Worsening
- Effusion may worsen after starting ATT or develop during treatment for parenchymal TB
- Represents immune reconstitution/paradoxical reaction
- Must first exclude wrong diagnosis; if TB confirmed, continue treatment
8. DIFFERENTIAL DIAGNOSIS OF LYMPHOCYTIC EXUDATE (1 mark)
| Condition | Distinguishing features |
|---|---|
| Malignant effusion | Positive cytology, low ADA, imaging |
| Lymphoma | Low ADA, LDH very high, CT mass |
| Parapneumonic effusion | PMN-predominant; ADA may be elevated |
| Rheumatoid pleurisy | Low glucose (<30 mg/dL), RF positive |
| Chylothorax | Triglycerides >110 mg/dL, milky |
| Fungal (Cryptococcus) | Immunocompromised, antigen titre |
9. COMPLICATIONS (1 mark)
| Complication | Notes |
|---|---|
| Fibrothorax/trapped lung | ~50% at 1 year; may rarely need decortication |
| TB empyema | Direct infection; purulent; culture positive; requires drainage ± surgery |
| Empyema necessitans | Rare; TB empyema decompresses percutaneously |
| Bronchopleural fistula | Complicates TB empyema especially after lung rupture |
| Paradoxical worsening | During ATT; immune reconstitution |
| MDR-TB | Consider if culture positive; MODS assay guides therapy |
SUMMARY TABLE (Quick Revision)
| Feature | TB Pleural Effusion |
|---|---|
| Type | Exudate (Light's criteria) |
| Side | Unilateral (almost always) |
| Cells | Lymphocyte-predominant (>50%) |
| ADA | >40 IU/L (highly sensitive + specific) |
| IFN-γ | >140 pg/mL |
| Glucose | Normal or reduced |
| Protein | Often >5 g/dL |
| Gold standard diagnosis | Pleural biopsy (caseating granuloma / AFB culture) |
| Treatment | 2HRZE + 4HR (same as pulmonary TB) |
| Steroids | Low-quality evidence; initiate after ATT |
| Resolution with treatment | Fever: 2 weeks; effusion: 6 weeks |
Sources: Murray & Nadel's Textbook of Respiratory Medicine (Chapter 109); Harrison's Principles of Internal Medicine 22E (Chapter on Pleural Disease); Goldman-Cecil Medicine; Sharma SK — Textbook of Tuberculosis and Nontuberculous Mycobacterial Diseases, 3rd Ed.; Light RW — Pleural Diseases.This is your complete, exam-ready 15-mark structured answer on Tuberculosis Pleural Effusion, compiled from Sharma Mohan's TB textbook, Murray & Nadel's Respiratory Medicine, Harrison's 22E, and Light's Pleural Diseases. Here's a quick map of how marks are distributed:
| Section | Marks |
|---|---|
| Introduction + Epidemiology | 1 |
| Pathogenesis (dual mechanism, spectrum concept) | 2 |
| Clinical Features | 2 |
| Radiology | 1 |
| Pleural Fluid Analysis + Diagnostic Markers | 3 |
| Diagnosis (stepwise approach, gold standard) | 2 |
| Treatment (ATT regimen, steroids, fibrinolytics) | 2 |
| DD of lymphocytic exudate | 1 |
| Complications | 1 |
| Total | 15 |
High-yield points examiners look for:
- Pathogenesis: paucibacillary + delayed hypersensitivity as a spectrum, not two separate disorders
- ADA >40 IU/L in a lymphocytic exudate = key diagnostic pointer
- IFN-γ >140 pg/mL — direct ELISA required (not IGRA)
- Pleural biopsy = gold standard; thoracoscopy = highest yield
- Treatment is identical to pulmonary TB: 2HRZE/4HR
- Paradoxical worsening during ATT is recognized and should not trigger treatment withdrawal
- Corticosteroids: low-quality evidence, always start ATT first
Where is the answer
The full answer is right above this message — scroll up. It's a long, detailed response. Here's the complete content again for convenience:
TUBERCULOSIS PLEURAL EFFUSION
MD Examination Answer — 15 Marks
1. INTRODUCTION & EPIDEMIOLOGY (1 mark)
Tuberculous pleural effusion is the most common cause of an exudative pleural effusion in many parts of the world. In Africa, pleural TB represents >30% of all TB cases (partly due to HIV co-infection). It is relatively uncommon in the US (~3.6% of TB cases). It may represent primary TB (3–6 months after initial infection) or reactivation TB.
2. PATHOGENESIS (2 marks)
Caused by rupture of a subpleural caseous focus into the pleural space, introducing mycobacterial antigens. Two overlapping mechanisms:
A. Delayed Hypersensitivity (Classical)
- Sensitised T-lymphocytes react to mycobacterial proteins → cytokine-driven vascular permeability → exudate
- Explains historically negative culture results (~80%)
B. Paucibacillary Direct Infection (Modern)
- Improved liquid culture + biopsy identifies bacilli in >60% of cases
- Initial neutrophilic acute inflammation → evolves to lymphocyte-driven chronic reaction + granuloma formation
- Lymphocyte activity inversely correlates with culture positivity
- Sufficient lymphocytic activity can sterilise the pleural space → explains spontaneous resolution
TB Pleuritis vs. TB Empyema — a spectrum, not two distinct diseases:
| Feature | TB Pleuritis | TB Empyema |
|---|---|---|
| Mechanism | Paucibacillary + immune reaction | High mycobacterial load |
| Fluid | Serous, lymphocytic exudate | Purulent |
| Culture | Usually negative | Positive |
| Spontaneous resolution | Possible | Unlikely |
In HIV co-infection: more systemic features, culture-positive effusions more common, more prevalent when CD4 >200 cells/μL.
3. CLINICAL FEATURES (2 marks)
Acute presentation (~2/3 cases): cough, pleuritic chest pain (~75%), fever, dyspnea — mimics bacterial pneumonia
Chronic presentation (~1/3 cases): low-grade fever, weakness, weight loss, night sweats
Effusion characteristics:
- Almost always unilateral
- Usually small to moderate in size (occasionally massive)
- Up to 86% have coexisting parenchymal disease — effusion always on the same side
- Even without radiographic parenchymal involvement, induced sputum is positive in ~55%
Rare complications: TB empyema (with pneumothorax + bronchopleural fistula), empyema necessitans, fibrothorax
4. RADIOLOGY (1 mark)
- CXR: unilateral homogeneous opacity; obliterated costophrenic angle; associated apical/upper lobe consolidation
- CT chest: encapsulated/loculated collections; smooth pleural enhancement ("split-pleura" sign); mediastinal lymphadenopathy; tree-in-bud nodules
- Ultrasound: free vs. loculated; guides thoracentesis
5. PLEURAL FLUID ANALYSIS (3 marks)
All TB effusions are exudates by Light's criteria:
- PF protein / serum protein > 0.5
- PF LDH / serum LDH > 0.6
- PF LDH > 2/3 upper limit of normal serum LDH
Biochemistry:
| Parameter | Finding |
|---|---|
| Protein | >3 g/dL; often >5 g/dL (characteristic of TB) |
| LDH | Elevated |
| Glucose | Normal or mildly reduced |
| pH | Normal (reduced in empyema) |
Cytology:
- Lymphocyte-predominant (hallmark) — small mature lymphocytes
- PMN predominance in ~11% (early disease)
- Mesothelial cells: characteristically absent or very sparse
Diagnostic Markers:
| Marker | Cut-off | Notes |
|---|---|---|
| ADA (Adenosine Deaminase) | >40 IU/L | Most clinically useful; released by T-lymphocytes; sensitivity ~90%, specificity ~90% |
| IFN-γ | >140 pg/mL | High accuracy; requires direct ELISA — NOT IGRA (insufficiently sensitive on PF) |
| PCR (mycobacterial DNA) | Positive | Variable sensitivity; high specificity |
| AFB culture (PF) | Positive | Low sensitivity (~30–40%); liquid media improves yield; gold standard if positive |
| AFB smear (PF) | Positive | Very low sensitivity (<20%) |
Key point: ADA + differential cell count + clinical context used in combination substantially improves diagnostic accuracy. ADA >50 IU/L in a lymphocytic exudate (Cecil's cut-off) is strongly suggestive.
6. DIAGNOSIS (2 marks)
Gold standard: Pleural biopsy showing caseating granulomas or positive AFB culture of biopsy tissue.
Stepwise Approach:
Step 1 — Thoracentesis
Send for: biochemistry, cytology + differential, AFB smear & culture, ADA, IFN-γ, PCR
Step 2 — Sputum
Induced sputum AFB smear + culture → positive in ~50% even without radiographic parenchymal involvement
MODS assay: liquid culture with drug susceptibility; faster, cheaper; WHO-approved for resource-limited settings
Step 3 — Pleural Biopsy (if above inconclusive)
- Thoracoscopy (medical / VATS): ideal — highest yield; direct visualization + directed biopsy
- Image-guided percutaneous needle biopsy: replaced closed biopsy in high-income settings
- Blind needle biopsy (Abrams needle): important in high-TB-prevalence/resource-limited settings; combine with ADA + differential; ultrasound guidance improves yield
- Biopsy culture yield > pleural fluid culture yield
Diagnostic criteria (any one):
- Caseating granuloma on pleural biopsy
- Positive AFB culture (fluid / biopsy / sputum)
- ADA >40 IU/L + lymphocytic exudate + compatible clinical picture + exclusion of alternative diagnoses
7. TREATMENT (2 marks)
Antituberculous Therapy (ATT)
Same regimen as pulmonary TB:
| Phase | Duration | Drugs |
|---|---|---|
| Intensive phase | 2 months | HRZE — 2HRZE |
| Continuation phase | 4 months | HR — 4HR |
| Total | 6 months |
(H = Isoniazid, R = Rifampicin, Z = Pyrazinamide, E = Ethambutol)
Response:
- Fever resolves: ~2 weeks
- Effusion resolves: ~6 weeks
- Residual pleural fibrosis: ~50% at 1 year (usually no functional impairment)
Corticosteroids
- May reduce time to resolution and residual fibrosis
- Evidence is low quality; more adverse events
- Always start ATT first, then add steroids if indicated
- Caution in HIV patients (possible Kaposi sarcoma risk)
Therapeutic Thoracentesis
- For large effusions causing significant dyspnea
- Not routinely required for small-moderate effusions on ATT
Intrapleural Fibrinolytics
- May improve drainage and reduce residual thickening
- Clinical benefit uncertain; not routine practice
Paradoxical Worsening
- Effusion worsens after starting ATT or new effusion develops during treatment for pulmonary TB
- First exclude wrong diagnosis; if TB confirmed → continue ATT (immune reconstitution reaction)
8. DIFFERENTIAL DIAGNOSIS OF LYMPHOCYTIC EXUDATE (1 mark)
| Condition | Key Distinguishing Feature |
|---|---|
| Malignant effusion | Positive cytology; low ADA; imaging mass |
| Lymphoma | Very high LDH; CT mediastinal mass |
| Rheumatoid pleurisy | Glucose <30 mg/dL; RF positive; low complement |
| Chylothorax | Triglycerides >110 mg/dL; milky fluid |
| Fungal (Cryptococcus) | Immunocompromised; antigen titre positive |
| Sarcoidosis | Bilateral; hilar lymphadenopathy; ACE elevated |
9. COMPLICATIONS (1 mark)
| Complication | Notes |
|---|---|
| Fibrothorax / Trapped lung | ~50% at 1 year; rarely requires decortication |
| TB Empyema | Purulent, culture positive; requires drainage ± surgery |
| Empyema necessitans | Rare; spontaneous percutaneous decompression |
| Bronchopleural fistula | Complicates TB empyema after lung rupture |
| Paradoxical worsening | During ATT; immune reconstitution |
| MDR-TB | Culture + drug susceptibility testing essential |
RAPID REVISION TABLE
| Feature | TB Pleural Effusion |
|---|---|
| Type | Exudate (Light's criteria) |
| Side | Unilateral (almost always) |
| Cells | Lymphocyte-predominant |
| ADA | >40 IU/L |
| IFN-γ | >140 pg/mL |
| Protein | Often >5 g/dL |
| Gold standard | Pleural biopsy (granuloma/AFB) |
| Treatment | 2HRZE + 4HR |
| Fever resolution | ~2 weeks |
| Effusion resolution | ~6 weeks |
| Residual fibrosis | ~50% at 1 year |
Sources: Murray & Nadel's Respiratory Medicine; Harrison's 22E; Goldman-Cecil Medicine; Sharma SK — Textbook of Tuberculosis & NTM Diseases, 3rd Ed; Light RW — Pleural Diseases
This is a shared conversation. Sign in to Orris to start your own chat.